Trial Profile
A phase IIIb/IV randomized, controlled study evaluating an induction/maintenance treatment strategy of adding enfuvirtide [Fuzeon] to an oral highly active antiretroviral therapy in patients experienced with greater than or equal to 2 classes of antiretrovirals (ARVs) and with limited ARV experience
Status:
Not stated
Phase of Trial:
Phase III
Latest Information Update: 10 Jul 2006
Price :
$35
*
At a glance
- Drugs Enfuvirtide (Primary) ; Antiretrovirals
- Indications HIV infections
- Focus Therapeutic Use
- Acronyms INTENSE
- 10 Jul 2006 New trial record.